ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $810,000 | -22.6% | 19,565 | +11.6% | 0.06% | -22.6% |
Q2 2022 | $1,046,000 | -10.4% | 17,530 | +9.0% | 0.08% | +44.8% |
Q1 2022 | $1,168,000 | -60.1% | 16,084 | -53.8% | 0.06% | -58.6% |
Q4 2021 | $2,927,000 | +265.4% | 34,806 | +292.1% | 0.14% | +97.2% |
Q3 2021 | $801,000 | -17.8% | 8,876 | -13.2% | 0.07% | -15.5% |
Q2 2021 | $975,000 | -17.2% | 10,225 | -1.1% | 0.08% | -25.0% |
Q1 2021 | $1,177,000 | -28.8% | 10,334 | -13.5% | 0.11% | -35.3% |
Q4 2020 | $1,653,000 | +79.3% | 11,942 | +6.5% | 0.17% | +53.1% |
Q3 2020 | $922,000 | +9.6% | 11,212 | +4.3% | 0.11% | +0.9% |
Q2 2020 | $841,000 | +108.2% | 10,749 | +18.3% | 0.11% | +51.4% |
Q1 2020 | $404,000 | -77.1% | 9,090 | -78.0% | 0.07% | -72.9% |
Q4 2019 | $1,762,000 | +10.7% | 41,249 | +10.9% | 0.27% | -0.4% |
Q3 2019 | $1,591,000 | -51.8% | 37,200 | -28.5% | 0.27% | -40.4% |
Q2 2019 | $3,302,000 | -35.1% | 52,000 | -29.1% | 0.46% | -27.6% |
Q1 2019 | $5,084,000 | +64.5% | 73,300 | +3.1% | 0.64% | +70.7% |
Q4 2018 | $3,091,000 | -51.2% | 71,100 | -14.3% | 0.37% | -38.4% |
Q3 2018 | $6,336,000 | +25.1% | 83,000 | +25.9% | 0.60% | +17.7% |
Q2 2018 | $5,066,000 | -7.0% | 65,900 | -38.3% | 0.51% | -1.9% |
Q1 2018 | $5,448,000 | +9.9% | 106,850 | 0.0% | 0.52% | +13.0% |
Q4 2017 | $4,956,000 | -27.5% | 106,850 | -16.7% | 0.46% | -18.5% |
Q3 2017 | $6,834,000 | -11.5% | 128,320 | +3.2% | 0.57% | -14.8% |
Q2 2017 | $7,722,000 | +6.0% | 124,320 | +15.7% | 0.67% | +6.2% |
Q1 2017 | $7,283,000 | +14.1% | 107,450 | +18.4% | 0.63% | +7.4% |
Q4 2016 | $6,381,000 | +5.5% | 90,750 | +6.5% | 0.58% | +14.3% |
Q3 2016 | $6,048,000 | – | 85,250 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 441,159 | $39,788,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,100 | $9,286,000 | 2.24% |
Rock Springs Capital Management LP | 801,109 | $72,252,000 | 1.52% |
Avidity Partners Management LP | 455,000 | $41,036,000 | 0.91% |
Motley Fool Asset Management LLC | 134,357 | $12,118,000 | 0.79% |
FEDERATED HERMES, INC. | 3,987,032 | $359,590,000 | 0.68% |
EMERALD ADVISERS, LLC | 196,124 | $17,688,000 | 0.64% |
Ergoteles LLC | 128,100 | $11,553,000 | 0.42% |
Tekla Capital Management LLC | 140,726 | $12,692,000 | 0.41% |
Beck Bode, LLC | 14,990 | $1,352,000 | 0.38% |